COVID-19

An update on COVID-19 advocacy activity and regulations affecting your pharmacy practice.

Here’s a roundup of the latest coronavirus-related news.

New survey results released by NCPA suggest that many Americans prefer to receive the COVID-19 vaccine from a local health care provider over a mass vaccination event.

The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.

In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.

Here's a roundup of the latest coronavirus-related news.

In a briefing this morning, the Infectious Diseases Society of America (IDSA) stressed the continued importance of COVID-19 control measures that have been there from the start.

Jon Copeland, president of AAP, joins Drug Topics® in this episode of Over the Counter to discuss key pharmacy industry trends, including digital health, the Amazon effect, PBM accountability, and pharmacy cooperatives.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.

Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.

The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine.

The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.

On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.

Here’s a roundup of the latest coronavirus-related news.

On Friday, an advisory panel will meet to evaluate the vaccine candidate and decide whether to recommend for emergency use authorization.

In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.

In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.

In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Members of the MJH Life Sciences™ COVID-19 Coalition recently weighed in on the latest coronavirus disease 2019 (COVID-19) pandemic news.

Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.

Here’s a roundup of the latest coronavirus-related news.

The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.

Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, spoke to Drug Topics about her role in getting their COVID-19 vaccination clinics off the ground.

The US government has purchased 100 million more vaccine doses for COVID-19 to stay ahead of increasing demand.